To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma

NCT04582539 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic Business Decision

Conditions

Myelodysplastic Syndromes
Multiple Myeloma
Anemia

Interventions

DRUG: INCB000928

Sponsor

Incyte Corporation